Tenaya Therapeutics (TNYA) Shares Outstanding (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Shares Outstanding (Entity) of $217.0 million for Q1 2026, up 97.51% year-over-year from $109.9 million in Q1 2025, and up 41.86% quarter-over-quarter from $153.0 million in Q4 2025.
Tenaya Therapeutics (TNYA) Shares Outstanding (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $217.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 97.51% year-over-year to $217.0 million; the TTM figure through Mar 2026 stood at $217.0 million (up 97.51% YoY), while the FY2025 annual figure was $153.0 million, up 76.76% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $217.0 million, up from $153.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $217.0 million in Q1 2026, with the low at $41.3 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $78.5 million (2024), against an average of $92.3 million.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) surged 3283.15% in 2022, then increased 16.21% in 2024.
- Tenaya Therapeutics' Shares Outstanding (Entity) stood at $44.8 million in 2022, then surged by 52.44% to $68.3 million in 2023, then advanced by 26.65% to $86.5 million in 2024, then surged by 76.76% to $153.0 million in 2025, then surged by 41.86% to $217.0 million in 2026.
- Business Quant data shows TNYA's Shares Outstanding (Entity) at $217.0 million in Q1 2026, $153.0 million in Q4 2025, and $163.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Tenaya Therapeutics | 151.50 Mn | 151.50 Mn | - | 217.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 217.57 Mn |
| Mar 31, 2026 | 216.88 Mn |
| Dec 31, 2025 | 152.97 Mn |
| Sep 30, 2025 | 163.35 Mn |
| Jun 30, 2025 | 162.79 Mn |
| Mar 31, 2025 | 109.87 Mn |
| Dec 31, 2024 | 84.82 Mn |
| Sep 30, 2024 | 86.16 Mn |
| Jun 30, 2024 | 85.71 Mn |
| Mar 31, 2024 | 80.98 Mn |
| Dec 31, 2023 | 73.79 Mn |
| Sep 30, 2023 | 73.92 Mn |
| Jun 30, 2023 | 73.40 Mn |
| Mar 31, 2023 | 73.10 Mn |
| Dec 31, 2022 | 44.82 Mn |
| Sep 30, 2022 | 41.36 Mn |
| Jun 30, 2022 | 41.30 Mn |
| Mar 31, 2022 | 41.27 Mn |
| Dec 31, 2021 | 17.73 Mn |
| Sep 30, 2021 | 26.90 Mn |